Outcomes after acute myocardial infarction in HIV-infected patients: Analysis of Data from a french nationwide hospital medical information database

Circulation

Volumn 127, Issue 17, 2013, Pages 1767-1774

  Lorgis, Luc ^a,b   Cottenet, Jonathan ^a   Molins, Guillaume ^a   Benzenine, Eric ^a   Zeller, Marianne ^b   Aube, Hervé ^a   Touzery, Claude ^a   Hamblin, Joelle ^a   Gudjoncik, Aurélie ^a,b   Cottin, Yves ^a,b   Quantin, Catherine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Epidemiology; HIV infections; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FRANCE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MEDICAL INFORMATICS APPLICATIONS; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84876990478     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.001874     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. Basic statistics from the Divisions of HIV/AIDS Prevention. http://www.cdc.gov/hiv/topics/surveil-lance/ basic.htm. 2010. Accessed April 9, 2013.
2. Yéni P. Rapport 2010 sur la prise en charge médicale des personnes infectées par le VIH. http://www.sante.gouv.fr/rapport-2010- sur-la-prise-en-charge-medicale-des-personnes-infectees-par-le-vih-sous-la- direction-du-pr-patrick-yeni.html. 2010. Accessed April 9, 2013.
3. Palella FJ J.r., Delaney KM, Moorman A.C., Loveless MO, Fuhrer J, Satten GA, Aschman D.J., Holmberg SD; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
4. Lewden C, May T, Rosenthal E., Burty C, Bonnet F, Costagliola D., Jougla E, Semaille C, Morlat P., Salmon D, Cacoub P, Chêne G. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590-598.
5. Lang S, Mary-Krause M, Cotte L., Gilquin J, Partisani M, Simon A., Boccara F, Bingham A, Costagliola D; French Hospital Database on HIV-ANRS CO4. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS. 2010;24:1228-1230.
6. Friis-Moller N., Reiss P, Sabin C.A., Weber R., Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E., Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-1735.
7. Mary-Krause M., Cotte L, Simon A., Partisani M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003;17:2479-2486.
8. Obel N, Thomsen HF, Kronborg G, Larsen C.S., Hildebrandt PR, Sørensen HT, Gerstoft J. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625-1631.
9. Triant VA, Lee H, Hadigan C., Grinspoon SK Increased acute myo-cardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506-2512.
10. Savès M., Chêne G, Ducimetière P, Leport C., Le Moal G, Amouyel P, Arveiler D., Ruidavets JB, Reynes J, Bingham A, Raffi F; French WHO MONICA Project and the APROCO (ANRS EP11) Study Group. Risk fiactors for coronary heart disease in patients treated for human immunode-ficiency virus infection compared with the general population. Clin Infect Dis. 2003;37:292-298.
11. Ambrose JA, Gould RB, Kurian D.C., DeVoe MC, Pearlstein NB, Coppola JT, Siegal FP Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection. Am J Cardiol. 2003;92:301-303.
12. Boccara F, Mary-Krause M, Teiger E., Lang S, Lim P, Wahbi K., Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard PM, Costagliola D, Cohen A; Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32:41-50.
13. Hsue PY, Giri K, Erickson S., MacGregor JS, Younes N, Shergill A, Waters DD Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004;109:316-319.
14. Matetzky S, Domingo M, Kar S., Noc M, Shah PK, Kaul S, Daar E., Cercek B. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003;163:457-460.
15. Varriale P, Saravi G, Hernandez E., Carbon F. Acute myocardial infarction in patients infected with human immunodeficiency virus. Am Heart J. 2004;147:55-59.
16. Boccara F, Ederhy S, Janower S., Benyounes N, Odi G, Cohen A. Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy. HIV Med. 2005;6:240-244.
17. Martín-Reyes R., Galeote G, Moreno R., Sánchez-Recalde A, López De Sá E, López-Sendón JL. Percutaneous coronary intervention in HIV infected patients with human immunodeficiency virus admitted with acute coronary syndrome: case-control study [in Spanish]. Med Clin (Barc). 2010;135:691-694.
18. Couris CM, Polazzi S, Olive F., Remontet L, Bossard N, Gomez F., Schott AM, Mitton N, Colonna M, Trombert B. Breast cancer incidence using administrative data: correction with sensitivity and specificity. J Clin Epidemiol. 2009;62:660-666.
19. Chantry AA, Deneux-Tharaux C, Cans C., Ego A, Quantin C, Bouvier-Colle MH; GRACE study group. Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity. J Clin Epidemiol. 2011;64:1014-1022.
20. Pearce D, Ani C, Espinosa-Silva Y, Clark R., Fatima K, Rahman M, Diebolt E., Ovbiagele B. Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals. Am J Cardiol. 2012;110:1078-1084.
21. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
22. Périard D., Telenti A, Sudre P., Cheseaux JJ, Halfon P, Reymond MJ, Marcovina S.M., Glauser MP, Nicod P, Darioli R, Mooser V. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors: the Swiss HIV Cohort Study. Circulation. 1999;100:700-705.
23. Rosengren A, Wallentin L, K Gitt A, Behar S, Battler A., Hasdai D. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J. 2004;25:663-670.
24. Goodman SG, Huang W, Yan A.T., Budaj A., Kennelly BM, Gore JM, Fox KA, Goldberg R.J., Anderson FA Jr; Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J. 2009;158:193-201.e1.
25. Danchin N, Puymirat E, Aissaoui N., Adavane S, Durand E. Epidemiology of acute coronary syndromes in France and in Europe [in French]. Ann Cardiol Angeiol (Paris). 2010;59(suppl. 2):S37-S41.
26. Fox KA, Steg PG, Eagle K.A., Goodman SG, Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A., Gore JM; GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297:1892-1900.
27. Rasmussen LD, Gerstoft J, Kronborg G., Larsen CS, Pedersen G, Obel N. Mortality after myocardial infarction in HIV-infected patients who have initiated HAART. AIDS. 2007;21:873-875.
28. Ren X, Trilesskaya M, Kwan D.M., Nguyen K., Shaw RE, Hui PY Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. Am J Cardiol. 2009;104:216-222.
29. Cerrato E, D'Ascenzo F, Biondi-Zoccai G, Calcagno A., Frea S, Grosso Marra W, Castagno D, Omedè P, Quadri G, Sciuto F, Presutti D, Frati G, Bonora S, Moretti C, Gaita F. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J. January 18, 2013. doi:10.1093/ eurheartj/ehs471. http://eurheartj.oxfordjournals.org/content/early/2013/01/17/ eurheartj.ehs471.long Accessed January 1, 2013.
30. Lipshultz SE, Mas CM, Henkel J.M., Franco VI, Fisher SD, Miller TL HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults. Expert Rev Anti Infect Ther. 2012;10:661-674.
31. Andréo C., Bouhnik AD, Soletti J, Bertholon D.R., Moatti JP, Rossert H, Spire B. Non-compliance in HIV-infected patients, supported by a community association [in French]. Santé Publique. 2001;13:249-262.
32. Singh N, Squier C, Sivek C., Wagener M, Nguyen MH, Yu VL Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261-269.
33. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
34. Freemantle N, Cleland J, Young P., Mason J, Harrison J. β Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730-1737.
35. Yusuf S, Sleight P, Pogue J., Bosch J, Davies R, Dagenais G; The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angio-tensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-153.
36. Yusuf S, Zhao F, Mehta S.R., Chrolavicius S., Tognoni G, Fox KK; Clopi-dogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
37. Puymirat E, Simon T, Steg P.G., Schiele F., Guéret P, Blanchard D., Khalife K, Goldstein P, Cattan S., Vaur L, Cambou JP, Ferrières J, Danchin N; USIK USIC 2000 Investigators; FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308:998-1006.
38. Crémieux A.C., D'Almeida KW, de Truchis P, Simon F, le Strat Y, Bousquet V, Semaille C., le Vu S, Lert F. Undiagnosed HIV prevalence based on non-targeted screening in emergency departments. AIDS. 2012;26:1445-1448.
39. Mark J. Atkinson, Jeffrey J. Petrozzino. An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications. AIDS Patient Care STDS. 2009;11: 903-914.